Morgan Stanley downgrades Lemonade to Equal-Weight, keeps target at $75
Morgan Stanley analyst Bob Huang downgraded Lemonade from Overweight to Equal-Weight. The firm maintained the price target at $75.

*this image is generated using AI for illustrative purposes only.
Morgan Stanley analyst Bob Huang downgraded Lemonade to Equal-Weight from Overweight while maintaining the price target at $75. The rating adjustment reflects a revised outlook on the stock following a period of Overweight status.
Rating and Target Details
The downgrade shifts Lemonade's status from a buy-equivalent rating to a neutral stance. Despite the lower rating, the price target remains unchanged at $75, indicating that the firm still sees upside potential relative to the current trading price.
| Metric | Previous | New |
|---|---|---|
| Rating | Overweight | Equal-Weight |
| Price Target | $75 | $75 |
What specific factors led Morgan Stanley to revise its outlook on Lemonade?
How might this downgrade influence investor sentiment towards Lemonade in the short term?
What are the key risks or challenges Lemonade faces that could impact its future performance?



























